| |
| |
|
| Insider
Information: |
Schaffer David |
| Relationship: |
Director |
| City: |
Amsterdam |
| State: |
P7 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
948,193 |
|
|
Indirect Shares
|
2,153,353 |
|
|
| Direct
Value |
$220,327 |
|
|
|
Indirect Value
|
$719,226 |
|
|
| Total
Shares |
3,101,546 |
|
|
| Total
Value |
$939,552 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -38.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
uniQure B.V. |
QURE |
Director |
2020-02-27 |
46,978 |
2017-01-01 |
153,353 |
Premium* |
|
|
4d Molecular Therapeutics Inc. |
FDMT |
Director |
2021-10-22 |
901,215 |
2020-12-10 |
2,000,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FDMT |
4d Molecular Therapeutics... |
Director |
– • – |
2021-10-22 |
4 |
AS |
$31.00 |
$58,893 |
D/D |
(1,900) |
901,215 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Director |
– • – |
2021-10-21 |
4 |
AS |
$31.56 |
$720,156 |
D/D |
(22,820) |
903,115 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Director |
– • – |
2021-10-20 |
4 |
AS |
$31.02 |
$358,771 |
D/D |
(11,565) |
925,935 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Director |
– • – |
2021-09-30 |
4 |
AS |
$26.69 |
$333,250 |
D/D |
(12,385) |
937,500 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Director |
– • – |
2021-09-29 |
4 |
AS |
$27.99 |
$482,614 |
D/D |
(16,871) |
949,885 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Director |
– • – |
2021-09-28 |
4 |
AS |
$30.52 |
$424,693 |
D/D |
(13,912) |
966,756 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Director |
– • – |
2021-09-27 |
4 |
AS |
$32.59 |
$635,826 |
D/D |
(19,332) |
980,668 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Director |
– • • |
2020-12-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,000,000 |
|
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2020-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,063 |
46,978 |
0 |
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2020-01-28 |
4 |
S |
$62.27 |
$50,190 |
D/D |
(806) |
44,915 |
0 |
% |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2019-01-28 |
4 |
S |
$31.31 |
$37,885 |
D/D |
(1,210) |
45,721 |
0 |
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,230 |
46,931 |
0 |
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2019-01-17 |
4 |
AS |
$30.71 |
$230,325 |
D/D |
(7,500) |
43,701 |
0 |
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2018-01-29 |
4 |
S |
$18.53 |
$53,329 |
D/D |
(2,878) |
15,314 |
0 |
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2018-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,792 |
18,192 |
0 |
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2017-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
153,353 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
